Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
View Patent ↗This invention provides recombinant polypeptides comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA), recombinant Listeria strains comprising same, and methods of inducing an anti-HMW-MAA and anti HER-2/neu immune response thus treating and impeding the growth of tumors, comprising administering same.
1. A method of delaying progression of a breast tumor in a subject, said method comprising the step of administering to said subject a composition comprising a recombinant Listeria strain expressing a recombinant nucleotide sequence encoding a recombinant polypeptide comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA) protein fused to a listeriolysin (LLO) protein, an ActA protein, or a PEST sequence, wherein said recombinant nucleotide sequence encoding said fragment is selected from the group consisting of SEQ ID NOs 21, 22, or 23, whereby said subject mounts an immune response against a HMW-MAA-expressing pericyte of a vasculature of said tumor, whereby said subject mounts an immune response against said pericyte of said vasculature of said tumor, thereby delaying progression of a breast tumor in a subject.
2. A method of treating, suppressing, or inhibiting a breast cancer in a subject, whereby said breast cancer is associated with expression of HER-2/neu antigen in said subject, said method comprising the step of administering to said subject a composition comprising a recombinant Listeria strain expressing a recombinant nucleotide sequence encoding a recombinant polypeptide comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA) protein fused to a listeriolysin (LLO) protein, an ActA protein, or a PEST sequence, wherein said recombinant nucleotide sequence encoding said fragment is selected from the group consisting of SEQ ID NOs 21, 22, or 23, whereby said subject mounts an immune response against HER-2/neu-expressing tumor, thereby treating, suppressing, or inhibiting a breast cancer in a subject.
3. A method of inducing a breast anti-tumor immune response in a subject comprising the step of administering to said subject a composition comprising a recombinant Listeria strain expressing a recombinant nucleotide sequence encoding a recombinant polypeptide comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA) protein fused to a listeriolysin (LLO) protein, an ActA protein, or a PEST sequence, wherein said recombinant nucleotide sequence encoding said fragment is selected from the group consisting of SEQ ID NOs 21, 22, or 23, whereby said subject mounts an immune response against a HMW-MAA-expressing pericyte of a vasculature of said tumor, whereby said composition kills the vasculature of said tumor and induces the release of a tumor antigen, thereby inducing a breast anti-tumor immune response.
4. A method of delaying progression of a breast tumor in a subject, said method comprising the step of administering to said subject a composition comprising a recombinant Listeria strain expressing a recombinant nucleotide sequence encoding a recombinant polypeptide comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA) protein fused to a listeriolysin (LLO) protein, an ActA protein, or a PEST sequence, wherein said recombinant nucleotide sequence encoding said fragment is selected from the group consisting of SEQ ID NOs 21, 22, or 23, whereby said subject mounts an immune response against a HMW-MAA-expressing pericyte of a vasculature of said tumor, whereby said subject mounts an immune response against a pericyte of a vasculature of said tumor, thereby delaying progression of a breast tumor in a subject.
5. A method of treating, suppressing, or inhibiting a breast cancer in a subject, whereby said cancer is associated with expression of HER-2/neu antigen in a subject, said method comprising the step of administering to said subject a composition comprising a recombinant Listeria strain expressing a recombinant nucleotide sequence encoding a recombinant polypeptide comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA) protein fused to a listeriolysin (LLO) protein, an ActA protein, or a PEST sequence, wherein said recombinant nucleotide sequence encoding said fragment is selected from the group consisting of SEQ ID NOs 21, 22, or 23, whereby said subject mounts an immune response against a HMW-MAA-expressing pericyte of a vasculature of a tumor from said cancer, thereby treating, suppressing, or inhibiting a breast cancer in a subject.
6. A method of inducing a breast anti-tumor immune response in a subject comprising the step of administering to said subject a composition comprising a recombinant Listeria strain expressing a recombinant nucleotide sequence encoding a recombinant polypeptide comprising a fragment of a High Molecular Weight Melanoma-Associated Antigen (HMW-MAA) protein fused to a listeriolysin (LLO) protein, an ActA protein, or a PEST sequence, wherein said recombinant nucleotide sequence encoding said fragment is selected from the group consisting of SEQ ID NOs 21, 22, or 23, whereby said subject mounts an immune response against a HMW-MAA-expressing pericyte of a vasculature of said tumor, whereby said composition kills the vasculature of said tumor and induces the release of a tumor antigen, thereby inducing a breast anti-tumor immune response.
7. A method for treating breast tumor cells expressing HER-2/neu in a subject, said method comprising administering to said subject a composition comprising a recombinant Listeria strain expressing a nucleotide sequence encoding a recombinant polypeptide, said recombinant nucleotide sequence is encoded by SEQ ID NO: 23 linked to an LLO polypeptide.